APO RESEARCH · REPORT
Marine Derived Drugs
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
Product & engineering
Understand the product.
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
Selected research
Market Structure
Global Marine Derived Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Most marine-derived compounds possess a few defining characteristics. First, often very low doses are given to patients, and they are administered almost exclusively via intravenous infusion (i.v.). The compounds are typically large molecules, especially the depsipeptides, and they are often hydrophobic. These attributes make them fascinating compounds in terms of pharmacokinetics but also from a bioanalytical point of view.
The first marine-derived compound approved by the United States (US) Food and Drug Administration (FDA) was cytarabine (Cytosar U®) in 1969, followed by trabectedin (Yondelis®),eribulin mesylate (Halaven®), brentuximab vedotin (Adcetris®), and midostaurin (Rydapt®) in the years 2007, 2010, 2011, 2013, and 2017, respectively.
Global Marine Derived Drugs key players include Seattle Genetics, Eisai Co, Tekada, Pfizer, Pharma Mar, etc. Global top five manufacturers hold a share about 85%.
Read the full market overview
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Mollusk is the largest segment, with a share about 50%. And in terms of application, the largest application is Antitumor Drugs, followed by Anti-Cardiovascular Drugs.
This report provides an overview of the global Marine Derived Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Marine Derived Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Marine Derived Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Marine Derived Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.
Marine Derived Drugs Segment by Company
Seattle Genetics
Eisai Co
Tekada
Pfizer
Pharma Mar
Johnson and Johnson
GSK
TerSera Therapeutics
Teva
Marine Derived Drugs Segment by Type
Mollusk
Sponge
Tunicate
Fish
Others
Marine Derived Drugs Segment by Application
Antitumor Drugs
Anti-Cardiovascular Drugs
Others
Marine Derived Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Marine Derived Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Marine Derived Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Marine Derived Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Marine Derived Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Marine Derived Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Marine Derived Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Marine Derived Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Mollusk
- Sponge
- Tunicate
- Fish
- Others
Applications
- Antitumor Drugs
- Anti-Cardiovascular Drugs
- Others
Companies covered
- Seattle Genetics
- Eisai Co
- Tekada
- Pfizer
- Pharma Mar
- Johnson and Johnson
- GSK
- TerSera Therapeutics
- Teva
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Marine Derived Drugs Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Marine Derived Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Marine Derived Drugs Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Marine Derived Drugs Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Marine Derived Drugs Market Dynamics
- 2.1 Marine Derived Drugs Industry Trends
- 2.2 Marine Derived Drugs Industry Drivers
- 2.3 Marine Derived Drugs Industry Opportunities and Challenges
- 2.4 Marine Derived Drugs Industry Restraints
3 Marine Derived Drugs Market by Manufacturers
- 3.1 Global Marine Derived Drugs Revenue by Manufacturers (2021-2026)
- 3.2 Global Marine Derived Drugs Sales by Manufacturers (2021-2026)
- 3.3 Global Marine Derived Drugs Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Marine Derived Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Marine Derived Drugs Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Marine Derived Drugs Manufacturers, Product Type & Application
- 3.7 Global Marine Derived Drugs Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Marine Derived Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Marine Derived Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Marine Derived Drugs Tier 1, Tier 2, and Tier 3
4 Marine Derived Drugs Market by Type
- 4.1 Marine Derived Drugs Type Introduction
- 4.1.1 Mollusk
- 4.1.2 Sponge
- 4.1.3 Tunicate
- 4.1.4 Fish
- 4.1.5 Others
- 4.2 Global Marine Derived Drugs Sales by Type
- 4.2.1 Global Marine Derived Drugs Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Marine Derived Drugs Sales by Type (2021-2032)
- 4.2.3 Global Marine Derived Drugs Sales Market Share by Type (2021-2032)
- 4.3 Global Marine Derived Drugs Revenue by Type
- 4.3.1 Global Marine Derived Drugs Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Marine Derived Drugs Revenue by Type (2021-2032)
- 4.3.3 Global Marine Derived Drugs Revenue Market Share by Type (2021-2032)
5 Marine Derived Drugs Market by Application
- 5.1 Marine Derived Drugs Application Introduction
- 5.1.1 Antitumor Drugs
- 5.1.2 Anti-Cardiovascular Drugs
- 5.1.3 Others
- 5.2 Global Marine Derived Drugs Sales by Application
- 5.2.1 Global Marine Derived Drugs Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Marine Derived Drugs Sales by Application (2021-2032)
- 5.2.3 Global Marine Derived Drugs Sales Market Share by Application (2021-2032)
- 5.3 Global Marine Derived Drugs Revenue by Application
- 5.3.1 Global Marine Derived Drugs Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Marine Derived Drugs Revenue by Application (2021-2032)
- 5.3.3 Global Marine Derived Drugs Revenue Market Share by Application (2021-2032)
6 Global Marine Derived Drugs Sales by Region
- 6.1 Global Marine Derived Drugs Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Marine Derived Drugs Sales by Region (2021-2032)
- 6.2.1 Global Marine Derived Drugs Sales by Region (2021-2026)
- 6.2.2 Global Marine Derived Drugs Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Marine Derived Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Marine Derived Drugs Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Marine Derived Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Marine Derived Drugs Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Marine Derived Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Marine Derived Drugs Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Marine Derived Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Marine Derived Drugs Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Marine Derived Drugs Revenue by Region
- 7.1 Global Marine Derived Drugs Revenue by Region
- 7.1.1 Global Marine Derived Drugs Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Marine Derived Drugs Revenue by Region (2021-2026)
- 7.1.3 Global Marine Derived Drugs Revenue by Region (2027-2032)
- 7.1.4 Global Marine Derived Drugs Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Marine Derived Drugs Revenue (2021-2032)
- 7.2.2 North America Marine Derived Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Marine Derived Drugs Revenue (2021-2032)
- 7.3.2 Europe Marine Derived Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Marine Derived Drugs Revenue (2021-2032)
- 7.4.2 Asia-Pacific Marine Derived Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Marine Derived Drugs Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Marine Derived Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Seattle Genetics
- 8.1.1 Seattle Genetics Company Information
- 8.1.2 Seattle Genetics Business Overview
- 8.1.3 Seattle Genetics Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Seattle Genetics Marine Derived Drugs Product Portfolio
- 8.1.5 Seattle Genetics Recent Developments
- 8.2 Eisai Co
- 8.2.1 Eisai Co Company Information
- 8.2.2 Eisai Co Business Overview
- 8.2.3 Eisai Co Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Eisai Co Marine Derived Drugs Product Portfolio
- 8.2.5 Eisai Co Recent Developments
- 8.3 Tekada
- 8.3.1 Tekada Company Information
- 8.3.2 Tekada Business Overview
- 8.3.3 Tekada Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Tekada Marine Derived Drugs Product Portfolio
- 8.3.5 Tekada Recent Developments
- 8.4 Pfizer
- 8.4.1 Pfizer Company Information
- 8.4.2 Pfizer Business Overview
- 8.4.3 Pfizer Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Pfizer Marine Derived Drugs Product Portfolio
- 8.4.5 Pfizer Recent Developments
- 8.5 Pharma Mar
- 8.5.1 Pharma Mar Company Information
- 8.5.2 Pharma Mar Business Overview
- 8.5.3 Pharma Mar Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pharma Mar Marine Derived Drugs Product Portfolio
- 8.5.5 Pharma Mar Recent Developments
- 8.6 Johnson and Johnson
- 8.6.1 Johnson and Johnson Company Information
- 8.6.2 Johnson and Johnson Business Overview
- 8.6.3 Johnson and Johnson Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Johnson and Johnson Marine Derived Drugs Product Portfolio
- 8.6.5 Johnson and Johnson Recent Developments
- 8.7 GSK
- 8.7.1 GSK Company Information
- 8.7.2 GSK Business Overview
- 8.7.3 GSK Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 GSK Marine Derived Drugs Product Portfolio
- 8.7.5 GSK Recent Developments
- 8.8 TerSera Therapeutics
- 8.8.1 TerSera Therapeutics Company Information
- 8.8.2 TerSera Therapeutics Business Overview
- 8.8.3 TerSera Therapeutics Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 TerSera Therapeutics Marine Derived Drugs Product Portfolio
- 8.8.5 TerSera Therapeutics Recent Developments
- 8.9 Teva
- 8.9.1 Teva Company Information
- 8.9.2 Teva Business Overview
- 8.9.3 Teva Marine Derived Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Teva Marine Derived Drugs Product Portfolio
- 8.9.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Marine Derived Drugs Value Chain Analysis
- 9.1.1 Marine Derived Drugs Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Marine Derived Drugs Production Mode & Process
- 9.2 Marine Derived Drugs Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Marine Derived Drugs Distributors
- 9.2.3 Marine Derived Drugs Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst